The protein insulin-like growth factor binding protein 2 has been described to be involved in neuroprotective and myelinogenetic effects (40), and has been found to be upregulated in the microglia/macrophages in active MS lesions (41). The gene discussed is IGFBP2; the disease is myeloid sarcoma.